📰 Bioscience Inc News
Page 32 - Bioscience Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bioscience Inc. Real-time updates on events, politics, business and more.
April 3, 2023
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the target of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 466,000 shares, a drop of 15.9% from the February 28th total of 554,100 shares. Based on an average daily trading volume, of 320,500 shares, […]
April 3, 2023
Local Bounti (NYSE:LOCL – Get Rating) and Yield10 Bioscience (NASDAQ:YTEN – Get Rating) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership. Profitability This table compares Local Bounti and Yield10 […]
April 3, 2023
HC Wainwright reissued their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Get Rating) in a report published on Friday morning, Benzinga reports. HC Wainwright currently has a $7.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2027 earnings at $0.80 EPS. Several other equities research analysts […]
April 2, 2023
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 466,000 shares, a drop of 15.9% from the February 28th total of 554,100 shares. Based on an average trading volume of 320,500 shares, the days-to-cover ratio is […]
April 1, 2023
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 466,000 shares, a decline of 15.9% from the February 28th total of 554,100 shares. Based on an average daily volume of 320,500 shares, the […]
April 1, 2023
HC Wainwright reaffirmed their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Get Rating) in a report published on Friday morning, Benzinga reports. They currently have a $7.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2027 earnings at $0.80 EPS. Several other research firms have also […]
March 30, 2023
/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...
March 30, 2023
SARASOTA, Fla., March 30, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) (
March 28, 2023
Origin Agritech (NASDAQ:SEED – Get Rating) and Yield10 Bioscience (NASDAQ:YTEN – Get Rating) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings. Profitability This table compares Origin Agritech and Yield10 […]
March 27, 2023
SARASOTA, Fla., March 27, 2023 /PRNewswire/ -- INVO Bioscience, Inc. , a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell®... | March 27, 2023